Stephen E. Epstein
National Center for Research Resources
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen E. Epstein.
Circulation | 1992
Philippe Douek; Rosaly Correa; R Neville; Ellis F. Unger; M Shou; Shmuel Banai; V J Ferrans; Stephen E. Epstein; Martin B. Leon; Robert F. Bonner
Pulsed infrared laser irradiation induced localized thermal lesions in arteries by transiently heating to ∼30°C above ambient and subsequent SMC proliferation in rabbits by 3–4 weeks. Neointimal proliferation exhibited a clear dose dependence both as laser fluence was increased (R=0.83) and for a fixed surface irradiation as the depth of the nearest arterial media was decreased (R=0.9S). Thermal injury to the arterial wall is shown to be potent stimulus for SMC proliferation, favoring reduction in energies used in laser or thermal angioplasty.
Archive | 1982
Martin B. Leon; Douglas R. Rosing; Stephen E. Epstein
Plasma verapamil levels were measured under various clinical conditions using a high-pressure liquid chromatography assay to determine their importance in guiding therapy in patients with hypertrophic cardiomyopathy. In 80 patients on chronic oral verapamil therapy, there was marked variability between patients in plasma verapamil levels for each dosage. In contrast, variability in peak and trough plasma verapamil levels for a given patientnwas relatively small (verapamil peak/trough ratio for 23 patients = 1.66 ±0.07). Plasma verapamil levels in 27 clinical responders, with improvement in NYHA functional class and >15% increase in exercise capacity, were not different from 15 nonresponders (responders = 153 ± 11, vs nonresponders = 175 ± 18 ng/ml (NS)). In 24 patients with serious electrophysiologic or hemodynamic side effects from verapamil, plasma verapamil levels ranged from 30 to 540 ng/ml (mean plasma verapamil level = 201 ± 23 ng/ml) and there was significant overlap in plasma verapamil levels compared with responders and nonresponders. Thus, in patients with hypertrophic cardiomyopathy on verapamil therapy (1) there is marked interpatient variability in plasma verapamil levels, which may be due to differences in first-pass hepatic metabolism and (2) there is considerable overlap of plasma verapamil levels in responders, nonresponders, and patients with serious side effects. Plasma verapamil levels therefore may be of limited usefulness in predicting therapeutic or toxic effects from oral verapamil therapy in patients with hypertrophic cardiomyopathy.
international conference of the ieee engineering in medicine and biology society | 1992
Philippe Douek; Rosaly Correa; Ellis F. Unger; Richard Neville; Shmuel Banai; Stephen E. Epstein; Martin B. Leon; Robert F. Bonner
Pulsed infrared laser irradiation induced localized thermal lesions in arteries by transiently heating to ∼30°C above ambient and subsequent SMC proliferation in rabbits by 3–4 weeks. Neointimal proliferation exhibited a clear dose dependence both as laser fluence was increased (R=0.83) and for a fixed surface irradiation as the depth of the nearest arterial media was decreased (R=0.9S). Thermal injury to the arterial wall is shown to be potent stimulus for SMC proliferation, favoring reduction in energies used in laser or thermal angioplasty.
Archive | 1994
Stephen E. Epstein; Edith Speir; Ellis F. Unger
Archive | 2001
Stephen E. Epstein; Shmuel Fuchs; Ran Kornowski
Archive | 1991
Ellis F. Unger; Stephen E. Epstein
Archive | 2001
Stephen E. Epstein; Shmuel Fuchs; Ran Kornowski
Archive | 2000
Ran Komowski; Shmuel Fuchs; Stephen E. Epstein; Martin B. Leon
Archive | 2003
Stephen E. Epstein; Shmuel Fuchs
Archive | 2004
Stephen E. Epstein; Shmuel Fuchs; Ran Kornowski; Martin B. Leon; Kenneth W. Carpenter